Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.31 +0.11 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Debt Ratio (2014 - 2021)

Updated

Rocket Pharmaceuticals' (RCKT) Debt Ratio stood at 0.01 in Q2 2021, up 10.2% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Debt Ratio (2014 - 2021) Analysis & Trends

Starting with Q4 2014, Rocket Pharmaceuticals' Debt Ratio history includes 5 quarters.

  • Quarterly Debt Ratio has ranged from 0.01 in Q4 2020 to 0.01 in Q3 2020 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 0.01 (Q1 2021), 0.01 (Q4 2020) and 0.01 (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Rocket Pharmaceuticals 258.98 Mn -24.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.01
Mar 31, 2021 0.01
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Dec 31, 2014 1.02
API Access

Rocket Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RCKT&period=max&api_key=YOUR_API_KEY